Related Experiment Video
Updated: May 17, 2026
11:37
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
Published on: February 18, 2015
NANOG modulates stemness in human colorectal cancer
J Zhang1, L A Espinoza, R J Kinders
1Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Oncogene
|October 23, 2012
Summary
NANOGP8, a NANOG retrogene, promotes cancer stemness in colorectal carcinoma (CRC) cells. It can substitute for NANOG, driving spheroid formation and tumor growth, and is found in liver metastases.
Area of Science:
- Cancer Biology
- Stem Cell Research
- Molecular Oncology
Background:
- NANOG is a crucial stem cell transcription factor involved in development and cancer.
- NANOGP8, a NANOG retrogene, is expressed in cancers but its function remains unclear.
- Colorectal carcinoma (CRC) progression involves cancer stem cells.
Purpose of the Study:
- To investigate the role of NANOGP8 in modulating stemness of human colorectal carcinoma (CRC) cells.
- To determine if NANOGP8 contributes to cancer progression and metastasis.
- To explore NANOGP8 as a potential therapeutic target in CRC.
Main Methods:
- In vitro assessment of stemness: spherogenicity and side population (SP) analysis.
- In vivo evaluation: tumorigenicity and experimental metastatic potential in NOD/SCID mice.
- Gene expression analysis (NANOG, NANOGP8, OCT4, SOX2) and protein translation confirmation.
- Functional assays using short hairpin RNA (shRNA) for NANOG inhibition and NANOGP8 overexpression.
Main Results:
- NANOGP8 transcripts were detected in 75% of NANOG-expressing liver metastases from CRC.
- NANOGP8 is translated into protein and promotes CRC cell spherogenicity and SP formation.
- Inhibition of NANOG by shRNA reduced stemness, proliferation, and tumor growth; NANOGP8 overexpression rescued these effects.
- NANOGP8 can functionally substitute for NANOG in promoting CRC stemness.
Conclusions:
- NANOGP8 directly promotes cancer stemness in colorectal carcinoma cells.
- NANOGP8 plays a significant role in CRC progression and metastatic potential.
- NANOGP8 represents a potential therapeutic target for colorectal cancer treatment.
Related Concept Videos
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:23Renewal of Intestinal Stem Cells
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
01:26Stem Cell Niche
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
01:06Multipotency and Niche of Bulge Stem Cell
A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...